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ABSTRACT 
Label-free quantitative phase imaging (QPI) is the hallmark of digital holographic microscopy (DHM). One of the most 
interesting medical applications of QPI-DHM is that it can be used to analyze illnesses in which the refractive index or/and 
the morphology of cells/tissues are distorted, from the acquisition of a single image. In this contribution, we obtain the 
phase maps of red blood cells (RBCs) samples of patients suffering from diabetes mellitus type 1 (DM1) by using a DHM. 
Our experimental results show that the measured phase values are significantly different between control non-diabetic and 
diabetic patients. The high correlation coefficient between the phase and the glycated hemoglobin (HbA1C) values 
determined by the gold standard method to screen diabetes and the clear separation between the two groups indicate that 
DHM may potentially be used to evaluate long-term glycemic control in diabetic patients as well as to diagnose diabetes.  
Keywords: digital holographic microscopy, phase retrieval, red blood cells, diabetes. 
1. INTRODUCTION
Diabetes mellitus (DM) is one of the top ten leading cause of death over the world. DM is a disease that includes a series 
of metabolic alterations that affect different organs and tissues due to a deficient production of insulin by the endocrine 
pancreas or by abnormal insulin action in peripheral tissues1,2. As a general classification, DM is classified into four broad 
categories3,4: type 1, type 2, gestational diabetes and others. The first types (type 1 and type 2) are the most prevalent and 
responsible for most of the health care cost attributed to this disease. Type 1 diabetes mellitus (T1DM) is characterized by 
the total loss of insulin5 and, consequently, T1DM patients require lifelong insulin injections since there are no alternative 
hormones in the organism mimicking the effect of insulin. Patient with type 2 DM (T2DM) are in a first phase of the 
disease insulin-resistant and the pancreas compensates by secreting high levels of the hormone. However, over time, T2DM 
often develops into T1DM. One characteristic of T1DM is that patients with T1DM present prominent fluctuations in 
blood glucose, with longer periods of hyperglycemia compared to non-diabetic individuals6,7. This results over time in the 
development of secondary complications that affect mainly the retina, kidneys, nerves and cardiovascular system8. The 
gold standard parameter to evaluate periodically glycemic control in patients with diabetes is the determination of glycated 
hemoglobin (HbA1C)9,10. The concentration of HbA1C indicates the level of exposure to persistent hyperglycemia over 
the last 2-3 months, coinciding with the half-life of hemoglobin (approximately 120 days), and it is measured by high-
performance liquid chromatography (HPLC). 
This study is devoted to analyze the alterations of the phase-map distributions using digital holographic microscopy 
(DHM) in erythrocytes of patients with diabetes compared to non-diabetic controls11. In DHM12–15, the reconstruction of 
the complex wavefield (amplitude and phase) of a microscopic sample is achieved by applying two processes in cascade. 
Firstly, one records the interference pattern between the complex amplitude distribution of the image of an object field 
produced by a host microscope and a reference plane wave. This stage is commonly named as the optical recording of a 
digital hologram. The second stage is the numerical (e.g. computational) recovery of the wavefield scattered by the object. 
After applying a numerical reconstruction approach, this technique allows us both numerical refocusing to different planes 
and the quantitative map of the phase distribution on the specimen under research. Thanks to these two features, DHM has 
become a crucial method for investigating biological cells16–21. The motivation of this work is based in two previous 
studies22,23. In the first, Mazarevica et al.22 reported that the refractive properties of the red blood cells (RBCs) in DM 
patients greatly differs from those of the healthy subjects. In fact, they demonstrated a relationship between the refractive 
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index changes in eyes of DM subjects and, as a result, transient myopia or hyperopia is derived23. As a proof-of-concept 
study, we have found that found that phase distribution of the RBC has the potential to be used to quantify persistent 
hyperglycemia states and, therefore even to be adopted as a screening method to diagnose abnormal hyperglycemia since 
there is a strong correlation between the measured phase and the HbA1C values. Note that in 1952, Barer24 demonstrated 
that hemoglobin concentration is linearly dependent on phase measurement. 
2. DIGITAL HOLOGRAPHIC MICROSCOPY (DHM)
As stated above, DHM can be understood as two independent stages: the optical recording of the hologram and, 
consequently, its reconstruction to retrieve both the amplitude and phase distributions of the sample under research. In this 
section, we provide a thorough description of the optical stage in DHM systems. In the recording stage, only the effects of 
diffraction and interference are taken into account. One of the most common optical configuration used in DHM is the 
modified Mach-Zenhder interferometer, shown in Fig. 1(a). The light proceeding from a laser of wavelength λ is collimated 
by a converging lens (CL) and the resultant plane beam impinges a cubic beam splitter (BS1). The split beams are usually 
known as the object and the reference waves. From Fig. 1 it is easy to realize that a conventional optical microscope, 
commonly called as the host microscope, is engaged in the object arm of the interferometer. The wavefield scattered by 
the specimen of amplitude distribution  is imaged by an imaging system composed by an infinity-corrected 
microscope objective (MO) and a tube lens (TL). Since the object is set at the front-focal plane (FFP) of the MO, the image 
of the sample, whose complex amplitude distribution is , is then obtained at the back-focal-plane (BFP) of the TL. 
Note that this plane is the image plane (IP) of the host microscope. 
Then, the irradiance pattern recorded by the sensor, called hologram, is the result of the optical interference between a 
tilted plane wave with the  wavefield propagated by a distance z from the IP. Without lack of generality, we have 
considered that the sensor plane coincides with the IP in Fig. 1a. This consideration does not affect the achieved lateral 
resolution of the DHM system25 and simplify the reconstruction steps. Further, to retrieve the sample information using a 
single-shot approach, the DHM systems operates in an off-axis configuration. This means that both the beam-splitter BS2 
and the mirror M2, which both reflect the reference wave R, are slightly tilted such as the reference wavefield interferes 
with the object wave O with an angle of ( , )θ θ= x xθ  with respect the optical axis, ( )xR ;θ . Thereby, the hologram ( )xH  
at the IP plane is 
( ) ( ) ( ) ( ) ( )22 * *( ) ( ) ,x x x x x x x= + + +IP IP IPH U R U R U R; ; ;θ θ θ     (1) 
where ( , )x y=x  are the spatial transverse coordinates, |·|2 represents the square modules and the sign * is the complex 
conjugate operation. From Eq. (1), one realizes that the hologram is composed by four terms. The first two terms do not 
carry any information about the phase of the object and the angle of the reference wave and they produce, when Fourier 
transformed, the zero-order of diffraction (e.g. the DC term). The DC term is always placed at the center of the Fourier 
transform of the hologram. The third and fourth terms are identified as the ±1 diffraction orders in the Fourier domain, 
respectively, and encode the whole sample information, both in amplitude and phase. Thanks to the off-axis configuration, 
the ±1 diffraction orders are arranged symmetrically around the DC term in the Fourier space. According to well-
established reconstruction methods, the object information can be obtained by spatially filtering out the +1 term26.  
Now, let us focus our attention to the object arm and the complex amplitude distribution of the object at the IP, ( )xIPU . 
Under the paraxial regime, the ( )xIPU  distribution can be computed by application in cascade of ABCD transformation27. 
After some mathematical manipulations, the  distribution is given by 
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where ( , )x y=x  are the spatial transverse coordinates, 2 /k π λ=  is the illumination wave number, 2⊗  denotes the 2D 
convolution operator, /TL MOM f f= −  stands for the lateral magnification of the host microscope, which only depends on 
the focal lengths of the MO ( MOf ) and the TL ( TLf ), and ( )p •  is the 2D Fourier Transform of the amplitude transmittance 
of the pupil. In Eq. (2), the quadratic phase term of curvature radius 2( ) / ( )TL TLC f f d= −  is well-known recognized in 
DHM and associated with the use of a non-telecentric imaging system28–30. This phase factor appears when the host 
microscope in the DHM follows a non-telecentric geometry,  being d  the distance between the BFP of the MO 
and the TL. As we have shown recently29,30, the existence of this quadratic phase term presents significant drawbacks on 
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phase measurements and the resolution capability introduced by a non-telecentric geometry of the imaging system. This 
additional phase factor turns the DHM into a shift-variant system which distorts phase measurements28,29. Besides the 
above, the non-telecentric DHM also presents limitations in amplitude contrast imaging. In fact, the presence of the 
quadratic phase term increases the size of the ±1 terms in the Fourier spectrum of the hologram. This broadening makes 
harder the spatial filtering of the +1 term in the reconstruction stage and can provide a deteriorated reconstructed image 
that the DHM system becomes a shift-variant imaging system30. 
Fig. 1 (a) Scheme of an off-axis transmission DHM. In a general case, the MO and the TL are arranged in non-telecentric 
mode (d ≠ fTL). (b) Illustration of the presence of a spherical distortion due to a non-telecentric geometry of the object arm in 
the 3D-pseudocolor QPI of a phase sample composed by radial stripes of different width. In the first row the DHM optical 
configuration does not operate in the telecentric regime (C=8000 mm and d = fTL – 5 mm = 195 mm) and the spherical factor 
introduced by the non-telecentric configuration has been eliminated via a posteriori numerical approach. In the second row 
the optical configuration operates at telecentric regime (C = ∞ and d = fTL). Note that in this case there is no presence of the 
remaining quadratic phase factor. The image area in the 3D QPIs is 0.521 × 1.203 mm2. 
Because the majority of off-axis DHMs reported in the literature operate in non-telecentric regime, we revise the effect of using a 
non-telecentric geometry in QPI-DHM. As shown in Fig, 1(b), the value of the radius of curvature C of the quadratic phase factor 
2exp(i / 2 )k Cx  in Eq. (2) depends on the distance between the MO aperture stop and the TL plane, d. Notwithstanding, this C-
parameter can be tuned by changing the separation between the MO and the TL. The direct consequence of this quadratic phase term is 
that the imaging system becomes shift-variant28,29. This means that the accuracy of the QPI measurements strongly depends on the 
position of the sample in the field of view (FOV). In non-telecentric QPI-DHM, this undesired quadratic phase factor is commonly 
eliminated a-posteriori via computational approaches. Mainly, the numerical approaches used to remove the phase factor require the 
accurate computation of its center and radius of curvature to cancel out its effect on QPI measurements. However, even a minimum 
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error in these parameters of the quadratic phase factor, perturbs the accuracy of the QPI-DHM, as shown in the second column of Fig. 
1(b). To evaluate the shift-invariance property between non-telecentric- and telecentric- DHM systems, we have reconstructed the phase 
map of a phase sample constituted by stripes of different width and equal height made on a glass substrate. We recorded two different 
holograms: one when the DHM operates in a non-telencetric regime with a C = 8000 mm (d = fTL – 5 mm = 195 mm) and the second 
one when the DHM system performs at the telectric mode (C = ∞ and d = fTL). The spherical phase factor introduced by the non-
telecentric arrangement has been eliminated using the common a posteriori numerical approach31–33. Note that although the spherical 
phase factor has been removed, the retrieved phase map still shows the presence of a remaining phase curvature which leads to a non-
invariant phase measurement, see first row in Fig. 1(b). Nonetheless, from the telecentric result (second row in Fig. 1b), one realizes that 
the phase measurement of the sample is homogeneous over the complete FOV since no presence of the remaining phase factor is 
observed. Note that this phase map is directly retrieved without applying any additional numerical process. Consequently, to ensure 
accurate QPI-DHM measurements (e.g. invariance of the phase measurement over the whole FOV) using a single-shot approach, which 
are without any doubt the desired feature in biological studies, the DHM must operate in telecentric mode.  
3. SCREENING DIABETES WITH A TELECENTRIC-BASED DHM
Our goal is to analyze if there are alterations in phase maps of RBCs between DM patients and non-diabetic controls. 
Based on these preliminary studies22,23, we analyze the alterations of the distributions of the phase maps using telecentric-
DHM. To face this task, samples are obtained from both non-diabetic individuals (14 controls) and 29 patients with T1DM 
who are under treatment with insulin injections. In this study, we need two different kind of samples. To perform the 
clinical measurements of HbA1C using HPLC, blood extracted from the antecubital vein is required. The other sample is 
directly a capillary blood drop to smear it on a glass slide. These smeared blood slides as used as the specimen in our 
telecentric-based DHM of Fig. 1 to image RBCs from both the healthy-control group and the T1DM patients using a 
telecentric-DHM. Fig. 2(a) illustrates the corresponding phase maps. For better visualization of the differences between 
these maps, all images have been pseudo-colored using the same color scale. According to the color bar, it is easy to note 
that the phase values of healthy RBCs (first row of Fig. 2a) RBCs are significantly smaller than those obtained for the 
T1DM group (second row of Fig. 2b). Owing to the sample is prepared as a smearing of a blood drop, the measured phase 
includes contributions of both the RBCs and the plasma components. To remove the latter, the average value of the phase 
over the areas free of RBCs is subtracted from the total phase. This procedure has been applied to the phase maps show in 
Fig. 2a. Then, the phase value over the RBCs is essentially provided by the optical path length along the cells. To compare 
these measurements with the one provided by the gold standard method, it is necessary to calculate a mean phase value for 
each participant. For each cell we obtain the phase as the average value over an area of approximately 1.12 × 1.12 μm2 
surrounding the centroid of the RBC. The mean phase value for each person is obtained as the average of the phase 
measurements of 20 individual erythrocytes. Fig. 2(b) shows the histograms of the RBC mean phase from healthy donors 
and diabetic patients whose average values were 3.15 ± 0.13 rad and 3.72 ± 0.15 rad, respectively. It is clear that phase 
values in the T1DM group are significantly higher than the healthy control group. Applying the Mann-Whitney test34,35 to 
assess if there are differences between control and diabetes groups with the phase measurement, we find that using DHM 
it is possible to divide the population into groups of healthy or T1DM patients with a very high significance level (p < 
0.001). In addition, from the results depicted in Fig. 2b, it is clear that the phase measurements of each group do not 
overlap. In fact, the average phase values in healthy RBCs ranges 2.94 - 3.30 rad, while T1DM RBCs are 3.51 - 4.01 rad. 
Therefore, we can conclude that phase values above 3.40 rad are an indication of diabetes. Although in this study, the 
whole analysis has been provided by using the phase measurement. It is worth to mention that the measured differences of 
the RBC phase values can be due to RI changes or morphological variations. To decouple both variations from the phase 
measurement, without any additional acquisition, we can measure the diameters of the RBCs for both groups of patients. 
Since the sample has been prepared leaving the RBCs free of mechanical constrains, one can assume that if a RBC 
experiences a morphological alteration, this modification will be present evenly along the three-directions. This means that 
if one cannot detect any change in the RBCs´ diameter it could be claimed that the cell height of a RBC does not change 
as well and there is no morphological alteration. We measure and average the diameter size over 30 individual erythrocytes 
of healthy and T1DM RBCs; the average values are 7.3 ± 0.6 µm and 7.6 ± 0.7 µm, respectively. Based on these 
measurements, one can conclude that no difference in the size can be detected for healthy and T1DM RBCs. Thus, the 
phase differences measured for both groups of RBCs, are mainly related to variations of the RI of the cells, as previously 
reported24. 
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Fig. 2 (a) Pseudo-colored image of the phase maps of healthy RBCs (first row) and T1DM-RBCs (second row) measured by 
our telecentric-DHM. (b) Histograms of mean phase values of the healthy control group and the T1DM participants obtained 
in panel (a). In all cases in panel (a), the image area is 9.38 × 9.38 μm2. 
In this study, we have also investigated if the measured phase values are correlated with HbA1C values. To this end, 
the phase values provided by our DHM are compared to the HbA1C data obtained by HPLC. The results can be observed 
in Fig. 3(a), where phase alterations are related to HbA1C changes. The rho correlation coefficients of Fig. 3(a) is 0.739 
with p < 0.01. Since the correlation coefficient between HbA1C and phase values is high and there is a clear separation 
between these two groups in Fig. 3(a), one can claim that both HbA1C and phase may potentially be used to diagnose 
diabetes states as well as to evaluate long-term glycemic control in patients with diabetes. Finally, we compare both 
methods (DHM and HPLC) by showing the boxplots of the standardized phase and HbA1C values for healthy and T1DM 
RBCs, see Fig. 3(b). From these results, we observe that their standardized phase and HbA1C parameters in patients with 
diabetes are higher than the ones obtained for the healthy participants. The corresponding variation interquartile range 
(IQR= Q3-Q1) is calculated to measure the statistical dispersion of each indicator. Whereas the IQR coefficient of the phase 
measurement is of 1.89 for healthy subjects and 1.72 for diabetic patients, in the case of the standardized HbA1C the value 
is lower than the phase values (1.01 and 1.26 for healthy and diabetic group, respectively). This observation indicates that 
the gold standard technique presents less dispersion and, consequently, is less sensitive to errors. Notwithstanding, the 
range of the measurements for HbA1C is higher than the one for phase values, see Fig. 3(b). In particular, the phase range 
is between 2.78 and 3.38 in comparison to the HbA1C range, which is between 4.04 and 5.03 for healthy and diabetic 
groups, in that order. According to this, the HPLC technique provides a wider range for controlling diabetes. Nonetheless, 
we believe that DHM technique could be used as the first method since only a capillary blood drop is needed, it can be 
performed in any time and the phase measurement is obtained in a fairly instantaneous way. 
Fig. 3 Comparison between the phase and HbA1C values. (a) Phase vs HbA1 values and (b) Boxplot between the standardized 
phase and HbA1c (the gold standard) values. For better visualization of the tendency between the values in panel (a), the least-
squared best-fit line has been plotted and the rho correlation coefficient has been provided.  
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4. CONCLUSIONS
In conclusion, we have demonstrated the use of telecentric-based DHM for DM screening. The utility of the DHM results 
from the possibility of providing quantitative phase maps as indicators of long-term blood sugar control similar to HbA1C. 
Although a strictly-medical research would require the analysis of much more test subjects, our results should be viewed 
as a proof-of-concept study. In addition, the proposed method shows great potential as optional tool to screen for diabetes 
because: (1) it is a minimally invasive technique since only a small drop of capillary blood is needed; (2) it can be 
performed at any time and the results can be obtained almost in real time; and (3) it is a widefield technique which can be 
easily implemented in a conventional microscope36, and (4) can be used to analyze illnesses in which the refractive index 
or/and the morphology are distorted. On the other hand, although HbA1C has been used clinically since the 1980s as a test 
of glycemic control in diabetes patients, the measurement of HbA1C provided by the HPLC method interferes with 
hemoglobinopathies and carbamylated Hb37. Apart from these drawbacks of the HbA1C measurement, the HPLC 
technique is also highly expensive. 
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